Alcohol and Cannabis Use Disorders Linked to Poorer ADHD Treatment Outcomes in Real-World Study
This study highlights the impact of adhd treatment cannabis use disorder on medication response in adults. Alcohol and cannabis use disorders reduce the likelihood of clinical improvement. Understanding these effects is crucial for managing ADHD with…
The association between major depressive disorder and cannabis use disorder: A meta-analysis and meta-regression analysis.
Major depressive disorder cannabis use is a critical area of study due to frequent co-occurrence. This meta-analysis examines prevalence estimates and clinical relevance. Understanding this association aids clinicians in patient care.
The association between major depressive disorder and cannabis use disorder: A meta-analysis and meta-regression analysis.
This meta-analysis on major depressive disorder cannabis use meta-analysis reveals significant prevalence of co-occurring conditions. It highlights the importance of integrated screening and treatment. Understanding this relationship is crucial for…
Clinical Insights on Cannabinoid Trials for PTSD and Substance Use
Cannabinoid clinical trials PTSD and substance use data provide critical insights into treatment outcomes for patients with co-occurring disorders. These trials show trauma-focused therapies remain effective regardless of cannabis use. Understanding this…
Cannabinoids and PTSD: Clinical Research on Trauma Care
Cannabinoids and PTSD clinical research reveals trauma-focused treatments benefit patients using cannabis with co-occurring substance use disorders. Evidence suggests clinicians should not delay PTSD care based on cannabis use alone. This research…
endocannabinoid system clinical research: REAL 2.0 Study
Clinical Takeaway The REAL 2.0 study tracked Canadian youth over 15 years to examine how early adolescent factors like body image and disordered eating contribute to mental health and substance use outcomes in early adulthood. Findings from this cohort…